LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction

Rebecca M. Minter, Xiaoming Bi, Gal Ben-Josef, Tianyi Wang, Bin Hu, Saman Arbabi, Mark R. Hemmila, Stewart C. Wang, Daniel G. Remick, Grace L. Su

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

It is generally accepted that low levels of lipopolysaccharide (LPS)-binding protein (LBP) augment the cell's response to LPS, whereas high levels of LBP have been shown to inhibit cell responses to LPS. Clinical studies and in vitro work by our group have demonstrated that, in the setting of liver disease, increased or acute-phase levels of LBP may actually potentiate rather than inhibit an overwhelming proinflammatory response. Therefore, in the present studies we sought to determine the role of acute-phase LBP in mediating morbidity and mortality in animals challenged with LPS in the setting of biliary obstruction. Using LBP-deficient mice and LBP blockade in wild-type mice, we demonstrate that high levels of LBP are deleterious in the setting of cholestasis. Following biliary obstruction and intraperitoneal LPS challenge, hepatic injury, hepatic neutrophil infiltration, and mortality were significantly increased in animals with an intact LBP acute-phase response. Kupffer cell responses from these animals demonstrated a significant increase in several inflammatory mediators, and Kupffer cell-associated LBP appears to be responsible for these differences, at least in part. Our results indicate that the role of LBP signaling in inflammatory conditions is complex and heterogeneous, and elevated levels of LBP are not always protective. Increased LBP production in the setting of cholestatic liver disease appears to be deleterious and may represent a potential therapeutic target for preventing overwhelming inflammatory responses to LPS in this setting.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume296
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Lipopolysaccharides
Mortality
Liver
Wounds and Injuries
Kupffer Cells
lipopolysaccharide-binding protein
Liver Diseases
Acute-Phase Reaction
Neutrophil Infiltration
Cholestasis
Morbidity

Keywords

  • Chemokines
  • Common bile duct ligation
  • Cytokines
  • Kupffer cells

ASJC Scopus subject areas

  • Physiology
  • Hepatology
  • Gastroenterology
  • Physiology (medical)

Cite this

LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction. / Minter, Rebecca M.; Bi, Xiaoming; Ben-Josef, Gal; Wang, Tianyi; Hu, Bin; Arbabi, Saman; Hemmila, Mark R.; Wang, Stewart C.; Remick, Daniel G.; Su, Grace L.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 296, No. 1, 01.01.2009.

Research output: Contribution to journalArticle

Minter, Rebecca M. ; Bi, Xiaoming ; Ben-Josef, Gal ; Wang, Tianyi ; Hu, Bin ; Arbabi, Saman ; Hemmila, Mark R. ; Wang, Stewart C. ; Remick, Daniel G. ; Su, Grace L. / LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2009 ; Vol. 296, No. 1.
@article{801aea7092a84c44aa66fa4cf829655b,
title = "LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction",
abstract = "It is generally accepted that low levels of lipopolysaccharide (LPS)-binding protein (LBP) augment the cell's response to LPS, whereas high levels of LBP have been shown to inhibit cell responses to LPS. Clinical studies and in vitro work by our group have demonstrated that, in the setting of liver disease, increased or acute-phase levels of LBP may actually potentiate rather than inhibit an overwhelming proinflammatory response. Therefore, in the present studies we sought to determine the role of acute-phase LBP in mediating morbidity and mortality in animals challenged with LPS in the setting of biliary obstruction. Using LBP-deficient mice and LBP blockade in wild-type mice, we demonstrate that high levels of LBP are deleterious in the setting of cholestasis. Following biliary obstruction and intraperitoneal LPS challenge, hepatic injury, hepatic neutrophil infiltration, and mortality were significantly increased in animals with an intact LBP acute-phase response. Kupffer cell responses from these animals demonstrated a significant increase in several inflammatory mediators, and Kupffer cell-associated LBP appears to be responsible for these differences, at least in part. Our results indicate that the role of LBP signaling in inflammatory conditions is complex and heterogeneous, and elevated levels of LBP are not always protective. Increased LBP production in the setting of cholestatic liver disease appears to be deleterious and may represent a potential therapeutic target for preventing overwhelming inflammatory responses to LPS in this setting.",
keywords = "Chemokines, Common bile duct ligation, Cytokines, Kupffer cells",
author = "Minter, {Rebecca M.} and Xiaoming Bi and Gal Ben-Josef and Tianyi Wang and Bin Hu and Saman Arbabi and Hemmila, {Mark R.} and Wang, {Stewart C.} and Remick, {Daniel G.} and Su, {Grace L.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1152/ajpgi.00041.2008",
language = "English (US)",
volume = "296",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction

AU - Minter, Rebecca M.

AU - Bi, Xiaoming

AU - Ben-Josef, Gal

AU - Wang, Tianyi

AU - Hu, Bin

AU - Arbabi, Saman

AU - Hemmila, Mark R.

AU - Wang, Stewart C.

AU - Remick, Daniel G.

AU - Su, Grace L.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - It is generally accepted that low levels of lipopolysaccharide (LPS)-binding protein (LBP) augment the cell's response to LPS, whereas high levels of LBP have been shown to inhibit cell responses to LPS. Clinical studies and in vitro work by our group have demonstrated that, in the setting of liver disease, increased or acute-phase levels of LBP may actually potentiate rather than inhibit an overwhelming proinflammatory response. Therefore, in the present studies we sought to determine the role of acute-phase LBP in mediating morbidity and mortality in animals challenged with LPS in the setting of biliary obstruction. Using LBP-deficient mice and LBP blockade in wild-type mice, we demonstrate that high levels of LBP are deleterious in the setting of cholestasis. Following biliary obstruction and intraperitoneal LPS challenge, hepatic injury, hepatic neutrophil infiltration, and mortality were significantly increased in animals with an intact LBP acute-phase response. Kupffer cell responses from these animals demonstrated a significant increase in several inflammatory mediators, and Kupffer cell-associated LBP appears to be responsible for these differences, at least in part. Our results indicate that the role of LBP signaling in inflammatory conditions is complex and heterogeneous, and elevated levels of LBP are not always protective. Increased LBP production in the setting of cholestatic liver disease appears to be deleterious and may represent a potential therapeutic target for preventing overwhelming inflammatory responses to LPS in this setting.

AB - It is generally accepted that low levels of lipopolysaccharide (LPS)-binding protein (LBP) augment the cell's response to LPS, whereas high levels of LBP have been shown to inhibit cell responses to LPS. Clinical studies and in vitro work by our group have demonstrated that, in the setting of liver disease, increased or acute-phase levels of LBP may actually potentiate rather than inhibit an overwhelming proinflammatory response. Therefore, in the present studies we sought to determine the role of acute-phase LBP in mediating morbidity and mortality in animals challenged with LPS in the setting of biliary obstruction. Using LBP-deficient mice and LBP blockade in wild-type mice, we demonstrate that high levels of LBP are deleterious in the setting of cholestasis. Following biliary obstruction and intraperitoneal LPS challenge, hepatic injury, hepatic neutrophil infiltration, and mortality were significantly increased in animals with an intact LBP acute-phase response. Kupffer cell responses from these animals demonstrated a significant increase in several inflammatory mediators, and Kupffer cell-associated LBP appears to be responsible for these differences, at least in part. Our results indicate that the role of LBP signaling in inflammatory conditions is complex and heterogeneous, and elevated levels of LBP are not always protective. Increased LBP production in the setting of cholestatic liver disease appears to be deleterious and may represent a potential therapeutic target for preventing overwhelming inflammatory responses to LPS in this setting.

KW - Chemokines

KW - Common bile duct ligation

KW - Cytokines

KW - Kupffer cells

UR - http://www.scopus.com/inward/record.url?scp=58249105899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58249105899&partnerID=8YFLogxK

U2 - 10.1152/ajpgi.00041.2008

DO - 10.1152/ajpgi.00041.2008

M3 - Article

C2 - 18948440

AN - SCOPUS:58249105899

VL - 296

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 1

ER -